Targeting the CCL2/CCR2 Axis in Cancer Immunotherapy: One Stone, Three Birds?

Liyang Fei, Yifan Zhan(Drug Discovery Laboratory (Norway))

Frontiers in Immunology

November 3, 2021

10.3389/fimmu.2021.771210

Cited by 201

Related Papers

No related papers found

Powered by citation graph analysis